(WMB) Williams Companies - Overview
Stock: Pipeline, Storage, Processing, Transportation, Marketing
| Risk 5d forecast | |
|---|---|
| Volatility | 23.2% |
| Relative Tail Risk | 0.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha | 28.88 |
| Character TTM | |
|---|---|
| Beta | 0.497 |
| Beta Downside | 0.853 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.36% |
| CAGR/Max DD | 3.40 |
EPS (Earnings per Share)
Revenue
Description: WMB Williams Companies March 02, 2026
Williams Companies (WMB) is a U.S.-based energy infrastructure firm that operates an extensive network of roughly 33,000 miles of interstate natural gas pipelines and associated storage, gathering, processing, and marketing assets across four segments: Transmission & Gulf of America, Northeast G&P, West, and Gas & NGL Marketing Services.
The Transmission & Gulf of America segment includes the Transco, NWP, and MountainWest pipelines plus Gulf Coast crude handling facilities; the Northeast G&P unit focuses on midstream services in the Marcellus and Utica shales; the West segment spans gathering and processing operations in the Rocky Mountains, Texas, Louisiana, and the Permian; while the Gas & NGL Marketing Services segment provides wholesale marketing, trading, and storage of natural gas and NGLs to utilities, power generators, and producers.
In its latest quarterly release (Q4 2023), Williams reported adjusted EBITDA of $2.4 billion and free cash flow of $2.6 billion, supporting a dividend yield near 5.5% and a capital-expenditure plan of $2.2 billion for 2024 aimed at pipeline upgrades and capacity expansions.
Key sector drivers include sustained growth in U.S. natural-gas demand for power generation and LNG export terminals, as well as rising NGL prices that bolster the profitability of the companys fractionation and marketing businesses.
For deeper insight, consider reviewing ValueRay’s analysis of WMB.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 2.62b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -2.81 > 1.0 |
| NWC/Revenue: -23.97% < 20% (prev -25.24%; Δ 1.27% < -1%) |
| CFO/TA 0.10 > 3% & CFO 5.90b > Net Income 2.62b |
| Net Debt (29.30b) to EBITDA (7.41b): 3.95 < 3 |
| Current Ratio: 0.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.22b) vs 12m ago -0.20% < -2% |
| Gross Margin: 57.17% > 18% (prev 0.59%; Δ 5658 % > 0.5%) |
| Asset Turnover: 21.11% > 50% (prev 19.26%; Δ 1.85% > 0%) |
| Interest Coverage Ratio: 3.51 > 6 (EBITDA TTM 7.41b / Interest Expense TTM 1.44b) |
Altman Z'' -0.66
| A: -0.05 (Total Current Assets 3.24b - Total Current Liabilities 6.11b) / Total Assets 58.57b |
| B: -0.21 (Retained Earnings -12.24b / Total Assets 58.57b) |
| C: 0.09 (EBIT TTM 5.07b / Avg Total Assets 56.55b) |
| D: -0.25 (Book Value of Equity -10.85b / Total Liabilities 43.58b) |
| Altman-Z'' Score: -0.66 = B |
Beneish M -3.01
| DSRI: 0.98 (Receivables 2.08b/1.86b, Revenue 11.94b/10.50b) |
| GMI: 1.03 (GM 57.17% / 58.71%) |
| AQI: 0.94 (AQ_t 0.23 / AQ_t-1 0.24) |
| SGI: 1.14 (Revenue 11.94b / 10.50b) |
| TATA: -0.06 (NI 2.62b - CFO 5.90b) / TA 58.57b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of WMB shares?
Over the past week, the price has changed by +4.49%, over one month by +14.95%, over three months by +27.70% and over the past year by +36.97%.
Is WMB a buy, sell or hold?
- StrongBuy: 8
- Buy: 4
- Hold: 8
- Sell: 0
- StrongSell: 2
What are the forecasts/targets for the WMB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 75.5 | -1% |
| Analysts Target Price | 75.5 | -1% |
WMB Fundamental Data Overview March 02, 2026
P/E Forward = 32.0513
P/S = 7.7183
P/B = 7.1491
P/EG = 2.538
Revenue TTM = 11.94b USD
EBIT TTM = 5.07b USD
EBITDA TTM = 7.41b USD
Long Term Debt = 27.32b USD (from longTermDebt, last quarter)
Short Term Debt = 2.04b USD (from shortTermDebt, last quarter)
Debt = 29.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.30b USD (from netDebt column, last quarter)
Enterprise Value = 120.61b USD (91.31b + Debt 29.36b - CCE 63.0m)
Interest Coverage Ratio = 3.51 (Ebit TTM 5.07b / Interest Expense TTM 1.44b)
EV/FCF = 134.2x (Enterprise Value 120.61b / FCF TTM 899.0m)
FCF Yield = 0.75% (FCF TTM 899.0m / Enterprise Value 120.61b)
FCF Margin = 7.53% (FCF TTM 899.0m / Revenue TTM 11.94b)
Net Margin = 21.93% (Net Income TTM 2.62b / Revenue TTM 11.94b)
Gross Margin = 57.17% ((Revenue TTM 11.94b - Cost of Revenue TTM 5.11b) / Revenue TTM)
Gross Margin QoQ = 46.84% (prev 83.89%)
Tobins Q-Ratio = 2.06 (Enterprise Value 120.61b / Total Assets 58.57b)
Interest Expense / Debt = 1.26% (Interest Expense 371.0m / Debt 29.36b)
Taxrate = 23.99% (244.0m / 1.02b)
NOPAT = 3.85b (EBIT 5.07b * (1 - 23.99%))
Current Ratio = 0.53 (Total Current Assets 3.24b / Total Current Liabilities 6.11b)
Debt / Equity = 2.29 (Debt 29.36b / totalStockholderEquity, last quarter 12.81b)
Debt / EBITDA = 3.95 (Net Debt 29.30b / EBITDA 7.41b)
Debt / FCF = 32.59 (Net Debt 29.30b / FCF TTM 899.0m)
Total Stockholder Equity = 12.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.63% (Net Income 2.62b / Total Assets 58.57b)
RoE = 20.84% (Net Income TTM 2.62b / Total Stockholder Equity 12.56b)
RoCE = 12.71% (EBIT 5.07b / Capital Employed (Equity 12.56b + L.T.Debt 27.32b))
RoIC = 9.52% (NOPAT 3.85b / Invested Capital 40.44b)
WACC = 6.10% (E(91.31b)/V(120.67b) * Re(7.75%) + D(29.36b)/V(120.67b) * Rd(1.26%) * (1-Tc(0.24)))
Discount Rate = 7.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF] Terminal Value 84.56% ; FCFF base≈1.49b ; Y1≈1.36b ; Y5≈1.22b
[DCF] Fair Price = 4.19 (EV 34.42b - Net Debt 29.30b = Equity 5.12b / Shares 1.22b; r=6.10% [WACC]; 5y FCF grow -10.33% → 2.90% )
EPS Correlation: 22.03 | EPS CAGR: 8.15% | SUE: -0.33 | # QB: 0
Revenue Correlation: 32.93 | Revenue CAGR: 6.51% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=-0.025 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.27 | Chg7d=+0.035 | Chg30d=+0.031 | Revisions Net=+2 | Growth EPS=+7.9% | Growth Revenue=+2.4%
EPS next Year (2027-12-31): EPS=2.57 | Chg7d=+0.075 | Chg30d=-0.135 | Revisions Net=-7 | Growth EPS=+13.3% | Growth Revenue=+11.1%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 7.9% - Earnings Yield 2.9%)
[Growth] Growth Spread = +2.5% (Analyst 7.6% - Implied 5.1%)